The past few decades have witnessed a furious attention of scientific
community towards identifying novel molecular factors and targets which could be
exploited for drug development for cancer management. One such factor is the
sirtuin (SIRT) family of nicotinamide adenine dinucleotide
(NAD+)-dependent deacetylases. The role of SIRTs in cancer is
extremely complex, with dichotomous functions depending on cell contexts.
Mammalian SIRTs (SIRT1–7), differ in their cellular localization and
biological functions. Amongst these, SIRT -3, -4, and -5 are located in the
mitochondria and are being carefully investigated. These mitochondrial SIRTs
(mtSIRTs) regulate multiple cellular and physiological processes, including cell
cycle, gene expression, cell viability, stress response, metabolism and energy
homeostasis. Recent research suggests that mtSIRTs influence tumors by
regulating the metabolic state of the cell. While the research on the role of
mtSIRTs in cancer is still in its infancy, studies have suggested tumor
suppressor as well as tumor promoter roles for them. This review is focused on
discussing an up-to-date information about the roles and functional relevance of
mtSIRTs (SIRT -3, -4, -5) in cancers. We have also provided a critical
discussion and our perspective on their dual roles, as tumor promoter
versus tumor suppressor, in cancer.